Transfusion free radical antegrade modular pancreaticosplenectomy of metastatic neuroendocrine tumor of the pancreas in Jehovah's Witness patient.
10.4174/astr.2015.88.2.106
- Author:
Young Bae JEON
1
;
Sangchul YUN
;
Dongho CHOI
Author Information
1. Department of Surgery, Soonchunhyang University College of Medicine, Cheonan, Korea.
- Publication Type:Case Report
- Keywords:
Neuroendocrine tumors;
Jehovah's witnesses;
Pancreatectomy;
Bloodless medical and surgical procedures
- MeSH:
Blood Transfusion;
Bloodless Medical and Surgical Procedures;
Disulfiram;
Erythropoietin;
Female;
Humans;
Iron;
Jehovah's Witnesses;
Middle Aged;
Neoplasm Metastasis;
Neuroectodermal Tumors, Primitive;
Neuroendocrine Tumors*;
Octreotide;
Pancreas*;
Pancreatectomy;
Patient Selection;
Sucrose
- From:Annals of Surgical Treatment and Research
2015;88(2):106-110
- CountryRepublic of Korea
- Language:English
-
Abstract:
In a popular sense, Jehovah's Witnesses (JW) have their creeds, one of which is refusal of blood transfusion. Such refusal may impinge on their proper management, especially in critical situations. We present a case of successful bloodless multimodality therapy, which was performed for a JW. The patient was a 49-year-old woman and JW who had general weakness 7 days before admission. She was diagnosed with a pancreatic neuroendocrine tumor (PNET) with hepatic metastases. Transcatheter arterial chemoembolization and Sandostatin LAR injection were performed, and then she was given a transfusion-free Radical antegrade modular pancreatosplenectomy sequentially. We gave recombinant human erythropoietin and iron hydroxide sucrose complex daily for five days after surgery. She was discharged at postoperative day 12 without any surgical complications. Multimodality therapy is very important for optimal treatment of PNET. Along with intimate interdepartmental cooperation, careful patient selection and appropriate perioperative management could possibly enhance the surgical outcome.
